Mepidental

Mepivacaine Hydrochloride, the active ingredient in Mepidental, is a local anesthetic presented as a solution for infiltration and perineural use. It provides temporary loss of sensation for dental procedures, minor surgical interventions, and other infiltration anesthesia applications. The drug acts by blocking voltage‑gated sodium channels, thereby preventing nerve impulse propagation in the targeted area.

GNH USA supplies Mepidental as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to Good Distribution Practice and provides regulatory documentation to support import and clinical use.

Mepidental, a local anesthetic, is used in procedures that require temporary loss of sensation in targeted tissues.

- Dental procedures: provides local anesthesia for tooth extractions and restorative work - Minor surgical procedures: enables infiltration anesthesia for skin and soft‑tissue surgeries - Infiltration anesthesia: achieves temporary numbness of specific tissue areas during minor interventions - Oral surgery: facilitates anesthesia for periodontal and implant procedures

Adverse reactions may occur following administration of Mepidental. Monitoring for both common and serious events is recommended.

Common Side Effects: - Transient numbness or tingling at the injection site - Mild dizziness or light‑headedness - Headache - Nausea - Metallic taste in the mouth - Mild swelling or erythema at the site

Serious or Rare Side Effects: - Allergic reaction including anaphylaxis - Cardiovascular collapse or severe hypotension - Seizures or central nervous system toxicity - Prolonged or profound numbness - Methemoglobinemia - Cardiac arrhythmias

When using Mepidental, clinicians should observe specific safety measures.

- Allergy assessment: verify no known hypersensitivity to amide‑type local anesthetics - Cardiac caution: avoid rapid intravascular injection in patients with cardiac disease - Dose limitation: use the lowest effective volume for the intended procedure - CNS monitoring: watch for signs of toxicity such as tinnitus or metallic taste - Drug interactions: consider potential additive effects with other sodium‑channel blockers - Store at below 25°C: keep in the original container, protect from moisture and direct sunlight

Mepidental may interact with other medications, altering its safety profile.

Major Interactions (Avoid): - Class I antiarrhythmics (e.g., quinidine, procainamide) – increased risk of cardiotoxicity - Epinephrine-containing solutions – may exacerbate cardiovascular effects - Other amide local anesthetics – cumulative toxicity risk

Moderate Interactions (Monitor Closely): - CYP450 inhibitors (e.g., cimetidine) – may raise plasma levels - Systemic antibiotics such as tetracyclines – potential additive neurotoxicity - Diuretics – may enhance plasma concentration - Antihistamines – may increase sedation or CNS effects